Cytokine production by whole blood cells: relationship to interleukin gene polymorphism and bone mass
- PMID: 16361815
- PMCID: PMC2779302
- DOI: 10.3346/jkms.2005.20.6.1017
Cytokine production by whole blood cells: relationship to interleukin gene polymorphism and bone mass
Abstract
The aims of this study were to investigate the relationships between the production of interleukin-1 (IL-1), and IL-6 system by whole blood cells, and bone mineral density (BMD), and polymorphisms in IL-1 system and IL-6 gene in postmenopausal Korean women. The production of IL-1alpha, IL-1beta, IL-1 receptor antagonist (IL-1ra), IL-6, and soluble IL-6 receptor (sIL-6r) by lipopolysaccharide-stimulated whole blood cells was measured by ELISA in 110 subjects. Serum osteocalcin, C-telopeptide of type I collagen, and BMD at lumbar spine and proximal femur were measured. IL-1alphaC(-889)T polymorphism, IL-1beta C(-511)T polymorphism, 86-base pair variable number tandem repeat polymorphism in the IL-1ra gene, and IL-6 C(-634)G polymorphism were analyzed. The production of IL-1beta correlated positively with BMD at femoral neck, whereas the production of other ILs did not correlate with BMD at the skeletal sites examined. No significant differences in the production of ILs were observed among normal, osteopenic and osteoporotic postmenopausal women, and among the different IL system polymorphisms groups studied. No correlation between bone turnover markers and the production of ILs was noted. In conclusion IL-1beta may regulate bone metabolism at femoral neck, and the IL system polymorphism do not affect the production of ILs by whole blood cells.
Similar articles
-
Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women.J Bone Miner Metab. 2006;24(1):53-7. doi: 10.1007/s00774-005-0646-z. J Bone Miner Metab. 2006. PMID: 16369899
-
Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.J Bone Miner Res. 2000 Mar;15(3):402-14. doi: 10.1359/jbmr.2000.15.3.402. J Bone Miner Res. 2000. PMID: 10750554
-
Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.J Bone Miner Res. 2000 Aug;15(8):1545-54. doi: 10.1359/jbmr.2000.15.8.1545. J Bone Miner Res. 2000. PMID: 10934653 Clinical Trial.
-
Nonassociation of interleukin-1 receptor antagonist genotypes with bone mineral density, bone turnover status, and estrogen responsiveness in Korean postmenopausal women.Bone. 2002 Nov;31(5):612-5. doi: 10.1016/s8756-3282(02)00873-6. Bone. 2002. PMID: 12477576
-
The Interleukin-1 (IL-1) Superfamily Cytokines and Their Single Nucleotide Polymorphisms (SNPs).J Immunol Res. 2022 Mar 26;2022:2054431. doi: 10.1155/2022/2054431. eCollection 2022. J Immunol Res. 2022. PMID: 35378905 Free PMC article. Review.
Cited by
-
MULTIDIRECTIONAL ASSESSMENT OF BONE STRUCTURE INCLUDING RADIOISOTOPIC ANALYSIS IN PERIMENOPAUSAL WOMEN.Acta Endocrinol (Buchar). 2018 Oct-Dec;14(4):439-446. doi: 10.4183/aeb.2018.439. Acta Endocrinol (Buchar). 2018. PMID: 31149294 Free PMC article.
-
Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women.Ann Saudi Med. 2010 Nov-Dec;30(6):437-41. doi: 10.4103/0256-4947.71062. Ann Saudi Med. 2010. PMID: 20940514 Free PMC article.
References
-
- Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement. 2000;17:1–45. - PubMed
-
- Romas E, Martin TJ. Cytokines in the pathogenesis of osteoporosis. Osteoporos Int. 1997;7(Suppl 3):47–53. - PubMed
-
- Khosla S, Peterson JM, Egan K, Jones JD, Riggs BL. Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab. 1994;79:707–711. - PubMed
-
- Giuliani N, Sansoni P, Girasole G, Vescovini R, Passeri G, Passeri M, Pedrazzoni M. Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol. 2001;36:547–557. - PubMed
-
- Hustmyer FG, Walker E, Yu XP, Girasole G, Sakagami Y, Peacock M, Manolagas SC. Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J Bone Miner Res. 1993;8:51–59. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical